Zealand Pharma Investor Relations Material
Latest events
Q1 2025
Zealand Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Zealand Pharma
Access all reports
Zealand Pharma, a biotechnology company, engages in discovery, development, and commercialization of peptide therapeutics for metabolic diseases, gastrointestinal diseases and diseases of the central nervous system in Denmark.
Key slides for Zealand Pharma
Q1 2025
Zealand Pharma
Q1 2025
Zealand Pharma
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
ZEAL
Country
🇩🇰 Denmark